In the evolving field of biochemical r Larazotide | CAS 258818-34-7 esearch, few compounds have garnered as much interest as the larazotide peptide. As someone deeply interested in how specific molecular structures interact with biological systems, I have spent significant time reviewin Celiac Disease Treatment Licensed and Headed to Late-Stage Clinical g the available literature on this fascinating octapeptide. Whether you are looking into its structural propertie Larazotideis apeptidewhich is an orally active zonulin antagonist.Larazotideshows antiviral activity to varicella-zoster virus (VZV) with EC50s of 44.14 and Read more s or its role in experimental settings, understanding the nuances of this compound is essential.
Structural Integrity and Mechanism
At its core, larazotide is a synthetic eight-amino acid peptide, often referred to as an octapeptide. Its specific sequence, H-Gly-Gly-Val-Leu-Val-Gln-Pro-Gly-OH, is what gives it its unique functional profile. Many researchers identify larazotide acetate (LA) as a synthetic, ei 7 Aug 2025—Larazotide, a synthetic peptide, targets the gut by blocking zonulin, strengthening intestinal barriers, and reducing hyperinflammation. In Read more ght amino acid peptide that serves as a potent tight junction regulator.
When observing the data, it becomes clear that larazotide is a peptide derived from the zonula occludens toxin produced by the bacterium *Vibrio cholerae*. By acting as a zonulin antagonist, it helps modulate the permeability of the intestinal lining. In my personal review of the topic, I have found that larazotide acetate is a synthetic peptide that targets the gut barrier by preventing the "opening" of these junctions, effectively maintaining a more closed, integral state.
Experimental Applications
The scientific community often categorizes larazotide (AT-1001) as a locally acting agent. Because larazotide acetate is a locally acting peptide restricted primarily Larazotide Acetate for Persistent Symptoms of to the luminal surface of the small intestine, it does not typically circulate systemically in the same way as other compounds.
In various research models, larazotide is designed to prevent the passage of gluten peptides across the intestinal barrier. This specific function is why many investigators study it in the context of reducing the impact or aiming to reduce the impact of gluten on the intestine. Furthermore, larazotide is a peptide therapy used to treat digestive concerns in preclinical trials, where it has been shown to improve the integrity of the intestinal lining.
The Role of Larazotide Acetate in Research
When navigating the complexities of this molecule, it is important to note that larazotide acetate is a novel, synthetic, eight-amino acid peptide that has been extensively documented in journals like the *American Journal of Physiology*.
As a researcher, I appreciate that larazotide acetate (LA) is recogn Larazotide Acetate for Persistent Symptoms of Celiac Disease - PMC ized for its stability and specificity. Because larazotide acetate (LA) can improve intestinal barrier function, it remains a subject of intense focus for those interested in the dynamics of tight junction proteins. Whether it is being used to study the reversal of "leaky" junctions or to explore its antiviral properties—such as its activity against the varicella-zoster virus (VZV)—the versatility of this compound is undeniable.
Key Considerations
For those asking about larazotide peptide, it is helpful to keep a few technical points in mind:
* Classification: It is an oligopeptide synthesized for high-precision laboratory use.
* Function: It is widely recognized as an orally active zonulin antagonist.
* Design: Larazotide is a synthetic eight-amino acid peptide tight junction regulator that prioritizes the maintenance of intercellular spaces.
* Formulation: It is most commonly utilized in its acetate salt form, which is why larazotide acetate is the standard nomenclature in most empirical studies.
Fi by ZM Slifer·2021·Cited by 53—Larazotide acetate (LA) is a single-chain peptide of eight amino acids that acts as a tight junction regulator to restore intestinal barrier function.Read more nal Thoughts
My exploration of larazotide has shown me that this compound represents a sophisticated intersection of microbio Discontinuation of Clinical Trial for Larazotide logy and synthetic chemistry. Because larazotide is a synthetic peptide that is relatively stable and well-characterized, it remains a pillar in the study of intestinal barrier physiology. While the research landscape is always shifting, the foundational understanding of how this peptide interacts with zonulin continues to provide valuable insights for those of us observing the development of next-generation biochemical tools.
*Disclaimer: This article is for educational and informational purposes based on publicly available scientific literature. It does not provide medical advice, diagnosis, or recommendations for human use.*